These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11094856)

  • 21. Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat.
    Ruiz-Carretero P; Nacher A; Merino-Sanjuan M; Casabo VG
    Int J Pharm; 2000 Jul; 202(1-2):89-96. PubMed ID: 10915930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal transport of cefuroxime axetil in rats: absorption and hydrolysis processes.
    Ruiz-Balaguer N; Nacher A; Casabo VG; Merino Sanjuan M
    Int J Pharm; 2002 Mar; 234(1-2):101-11. PubMed ID: 11839441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacology of Cefuroxime as the 1-acetoxyethyl ester in volunteers.
    Harding SM; Williams PE; Ayrton J
    Antimicrob Agents Chemother; 1984 Jan; 25(1):78-82. PubMed ID: 6703686
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Investigation of adsorption, metabolism and excretion of cefuroxime axetil in volunteers of gastrectomized patients].
    Ishibiki K; Inoue S; Suzuki F; Okumura K; Takeda K; Toshimitsu Y
    Jpn J Antibiot; 1990 Feb; 43(2):337-44. PubMed ID: 2362355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of malnutrition on the pharmacokinetics of cefuroxime axetil in young rats.
    González-Hernández I; Jung-Cook H; Sotelo A
    J Pharm Pharm Sci; 2008; 11(1):9-21. PubMed ID: 18445361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of cefuroxime axetil in patients with normal and impaired renal function.
    Konishi K; Suzuki H; Hayashi M; Saruta T
    J Antimicrob Chemother; 1993 Mar; 31(3):413-20. PubMed ID: 8486575
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells.
    Dantzig AH; Duckworth DC; Tabas LB
    Biochim Biophys Acta; 1994 Apr; 1191(1):7-13. PubMed ID: 8155686
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring antibiotic levels in otitis media.
    Thoroddsen E
    Ear Nose Throat J; 1998 Jun; 77(6 Suppl):13-5. PubMed ID: 9674329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penetration of cefuroxime into chronically inflamed sinus mucosa.
    Dinis PB; Monteiro MC; Lobato R; Martins ML; Gomes A
    Laryngoscope; 1999 Nov; 109(11):1841-7. PubMed ID: 10569419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Penetration of cefetamet pivoxil and cefuroxime axetil into the maxillary sinus mucosa at steady state.
    Stoeckel K; Harell M; Dan M
    Antimicrob Agents Chemother; 1996 Mar; 40(3):780-3. PubMed ID: 8851611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and characterization of cefuroxime axetil biphasic floating minitablets.
    Jammula S; Patra ChN; Swain S; Panigrahi KC; Nayak S; Dinda SC; Rao ME
    Drug Deliv; 2015 Jan; 22(1):125-35. PubMed ID: 24417642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suitability of cefotiam and cefuroxime axetil for the perioperative short-term prophylaxis in tonsillectomy patients.
    Müller R; Böttger C; Wichmann G
    Arzneimittelforschung; 2003; 53(2):126-32. PubMed ID: 12642969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of cefaclor and cefuroxime axetil in the treatment of acute otitis media with effusion in children who failed amoxicillin therapy.
    Turik MA; Johns D
    J Chemother; 1998 Aug; 10(4):306-12. PubMed ID: 9720470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New semiphysiological absorption model to assess the pharmacodynamic profile of cefuroxime axetil using nonparametric and parametric population pharmacokinetics.
    Bulitta JB; Landersdorfer CB; Kinzig M; Holzgrabe U; Sorgel F
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3462-71. PubMed ID: 19528278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics and tolerance of cefuroxime axetil in volunteers during repeated dosing.
    Sommers DK; Van Wyk M; Williams PE; Harding SM
    Antimicrob Agents Chemother; 1984 Mar; 25(3):344-7. PubMed ID: 6721467
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of the serum and tissue concentrations of cefuroxime from cefuroxime axetil and phenoxymethylpenicillin in patients undergoing tonsillectomy.
    Jetlund O; Thurmann-Nielsen E; Walstad RA
    Int J Clin Pharmacol Res; 1991; 11(1):1-6. PubMed ID: 1908443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral cefuroxime axetil: clinical pharmacology and comparative dose studies in urinary tract infection.
    Adams DH; Wood MJ; Farrell ID; Fox C; Ball AP
    J Antimicrob Chemother; 1985 Sep; 16(3):359-66. PubMed ID: 4055543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cefuroxime axetil in the treatment of uncomplicated UTI: a comparison with cefaclor and augmentin.
    Williams KJ; Hebblethwaite EM; Brown GW; Cox DM; Plested SJ
    Drugs Exp Clin Res; 1987; 13(2):95-9. PubMed ID: 3556123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An evaluation of the safety of cefuroxime axetil during six months oral administration to beagle dogs.
    Spurling NW; Harcourt RA; Hyde JJ
    J Toxicol Sci; 1986 Nov; 11(4):237-77. PubMed ID: 3820342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.